The field of nanomedicine is providing new drug delivery approaches to address metastatic cancer, a leading cause of mortality. By utilizing nanoscale formulations, researchers aim to improve targeting of metastatic tumors, enhance bioavailability and reduce systemic toxicity compared to conventional therapies. Recent reviews highlight the promise of nanotechnology to tackle the complex biological processes underlying cancer metastasis and improve patient outcomes through precision intervention.